- Home
- FBIOP vs UTF Comparison
FBIOP vs UTF Comparison
Compare FBIOP & UTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- UTF
- Stock Information
- Founded
- FBIOP N/A
- UTF 2004
- Country
- FBIOP United States
- UTF United States
- Employees
- FBIOP 101
- UTF N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- UTF Finance Companies
- Sector
- FBIOP Health Care
- UTF Finance
- Exchange
- FBIOP Nasdaq
- UTF Nasdaq
- Market Cap
- FBIOP N/A
- UTF N/A
- IPO Year
- FBIOP N/A
- UTF N/A
- Fundamental
- Price
- FBIOP $9.47
- UTF $26.34
- Analyst Decision
- FBIOP
- UTF
- Analyst Count
- FBIOP 0
- UTF 0
- Target Price
- FBIOP N/A
- UTF N/A
- AVG Volume (30 Days)
- FBIOP N/A
- UTF 187.6K
- Earning Date
- FBIOP N/A
- UTF 01-01-0001
- Dividend Yield
- FBIOP N/A
- UTF 7.06%
- EPS Growth
- FBIOP N/A
- UTF N/A
- EPS
- FBIOP N/A
- UTF 2.84
- Revenue
- FBIOP N/A
- UTF $138,636,669.00
- Revenue This Year
- FBIOP N/A
- UTF N/A
- Revenue Next Year
- FBIOP N/A
- UTF N/A
- P/E Ratio
- FBIOP N/A
- UTF $9.28
- Revenue Growth
- FBIOP N/A
- UTF 19.80
- 52 Week Low
- FBIOP N/A
- UTF $22.05
- 52 Week High
- FBIOP N/A
- UTF $26.53
- Technical
- Relative Strength Index (RSI)
- FBIOP 85.14
- UTF 64.33
- Support Level
- FBIOP $6.43
- UTF $26.00
- Resistance Level
- FBIOP $7.00
- UTF $26.53
- Average True Range (ATR)
- FBIOP 0.41
- UTF 0.32
- MACD
- FBIOP 0.25
- UTF 0.02
- Stochastic Oscillator
- FBIOP 99.37
- UTF 83.62
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.